Determining the toxicity of biologically active chemical substances
Korneĭchuk, E.P.; Datsenko, I.I.; Petrus, V.S.
Gigiena i Sanitariia 9: 38-39
1988
ISSN/ISBN: 0016-9900 PMID: 3234803 Document Number: 307379
Document emailed within 1 workday
Related Documents
Gostishchev, V.K.; Nikolaev, A.V.; Shekhter, A.B.; Vert'ianov, V.A.; Shapiro, A.M. 1986: Diadynamophoresis of chemical and biologically active substances in the treatment of suppurative and inflammatory diseases in diabetes mellitus Vestnik Khirurgii Imeni I. I. Grekova 137(8): 63-66Beliavskaia, L.A.; Kozyritskaia, V.E.; Valagurova, E.V.; Iutinskaia, G.A. 2012: Biologically active substances of preparation avercom Mikrobiolohichnyi Zhurnal 74(3): 10-15
Wiśniewski, K. 1979: Some aspects of interaction of biologically active substances in the CNS Polish Journal of Pharmacology and Pharmacy 31(4): 347-358
Miasishcheva, N.V.; Artemova, E.N. 2013: Biologically active substances of black currant of new varieties Voprosy Pitaniia 82(5): 68-71
Beker, M.E. 1973: Some aspects of the microbial synthesis of biologically active substances Mikrobiolohichnyi Zhurnal 35(1): 83-87
Orlinskiĭ, M.M.; Zimenkovskiĭ, B.S.; Mazur, I.A.; Stets, V.R.; Stebliuk, P.N. 1996: The prospects of the search for biologically active substances among noncondensed thiazolidones-2 Eksperimental'naia i Klinicheskaia Farmakologiia 59(5): 59-61
Aleksandrowicz, J.; Fiejka, M.; Kudelski, Z.; Marciniak-Rusek, A.; Paśś-Dziegielewska, L. 1996: LAL test used for detection of undesirable biologically active substances in biopreparations Medycyna Doswiadczalna i Mikrobiologia 48(3-4): 215-221
Musiał, W.; Kubis, A.A. 2005: Some interactions of natural and synthetic anionic polymers with biologically active substances Polimery W Medycynie 35(1): 39-46
Novikov, V.S.; Bortnovskiĭ, V.N.; Mastriukov, A.A.; Lotovin, A.P.; Arzumanov, A.A. 1987: Efficacy of the use of biologically active substances to increase the body resistance in sailors Voenno-Meditsinskii Zhurnal 10: 50-51
Smirnov, V.V.; Sorokulova, I.B.; Pinchuk, I.V. 2001: Bacteria of Bacillus species--prospective source for biologically active substances Mikrobiolohichnyi Zhurnal 63(1): 72-79
Rozhanskaia, T.I.; Margolina, N.A.; Podsukhina, G.M.; Selezneva, A.A.; Dubiaga, V.P. 1976: Permeability of acetylcellulose ultrafiltration membranes with regard to biologically active substances Prikladnaia Biokhimiia i Mikrobiologiia 12(2): 287-290
Iakovleva, E.P. 1983: Joint cultivation of the producers of biologically active substances with other microorganisms (a review) Prikladnaia Biokhimiia i Mikrobiologiia 19(3): 330-346
Piotrovich, A.K.; Golovkova, N.F.; Kaluzhskaia, V.I.; Uchaĭkin, G.F.; Chverkaliuk, T.E. 1985: Role of biologically active substances in the pathogenesis of meningococcal infection in children Pediatriia 7: 50-51
Dadali, V.A.; Makarov, V.G. 2003: Biologically active substances from medicinal plants as a factor of the organism detoxication Voprosy Pitaniia 72(5): 49-55
Pokrovskiĭ, V.I.; Maleev, V.V.; Zborovskiĭ, A.B.; Efremenko, V.I.; Gontar', I.P.; Tiumentseva, I.S.; Afanas'ev, E.N. 2003: Use of affinity interaction of biologically active substances in practice of public health system Terapevticheskii Arkhiv 75(11): 42-46
Korpachev, V.V.; Shostak, I.N. 1990: The effect of biologically active substances from the spleen on the content of somatotropic hormone in the rat hypophysis Problemy Endokrinologii 36(5): 82-85
Korochkin, I.M.; Katsman, R.F.; Vinogradova, I.V.; Matveeva, I.V.; Dudaev, V.A. 1974: Content of biologically active substances in blood of patients with congestive circulatory insufficiency Kardiologiia 14(7): 151-155
Adaikan, P.G.; Zaman, V. 1982: In vitro activity of anthelmintic drugs and biologically active substances on Breinlia booliati Southeast Asian Journal of Tropical Medicine and Public Health 13(2): 257-261
Karpin, V.A. 1988: Metabolism of biologically active substances in patients with chronic suppurative diseases of the lungs Vrachebnoe Delo 5: 58-60
Afinogenov, G.E.; Kopylova, T.V.; Vladimirov, N.I.; Briantseva, L.N. 1984: Prevention of the formation of drug resistance in bacterial populations by using biologically active substances Antibiotiki 29(6): 417-421